Drug Profile
CI 1002
Alternative Names: PD 142676Latest Information Update: 27 Oct 1999
Price :
$50
*
At a glance
- Originator Pfizer
- Class Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 27 Oct 1999 Discontinued-I for Alzheimer's disease in USA (PO)
- 21 Jul 1999 No-Development-Reported for Alzheimer's disease in USA (PO)
- 10 Mar 1997 Phase-I clinical trials for Alzheimer's disease in USA (PO)